Lithium Provides Broad Therapeutic Benefits in an Alzheimer’s Disease Mouse Model
Journal of Alzheimer's Disease · 03.01.2023 · 91 (1) · 273-290
DOI: 10.3233/jad-220758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 03.01.2023. Verfasst von Alyssa L Wiseman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Neuroscience, The Chicago Medical School, Rosalind Franklin University, North Chicago, IL, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder with a progressive loss of cognitive function. Currently, no effective treatment regimen is available. Lithium, a mood stabilizer for bipolar disorder, exerts broad neuroprotective and neurotrophic actions and improves cognitive function.
Objective
The study investigated if lithium stabilizes Ca2+ signaling abnormalities in hippocampal neurons and subsequently normalize downstream effects on AD neuropathology and synaptic plasticity in young AD mice.
Methods
Four-month-old 3xTg-AD mice were treated with a LiCl diet chow for 30 days. At the end of the lithium treatment, a combination of two-photon Ca2+ imaging, electrophysiology, and immunohistochemistry assays were used to assess the effects of the LiCl treatment on inositol trisphosphate receptor (IP3R)-dependent endoplasmic reticulum (ER) Ca2+ and voltage-gated Ca2+ channel (VGCC)-mediated Ca2+ signaling in CA1 neurons, neuronal nitric oxide synthase (nNOS) and hyperphosphorylated tau (p-tau) levels and synaptic plasticity in the hippocampus and overlying cortex from 3xTg-ADmice.
Results
Thirty-day LiCl treatment reduced aberrant IP3R-dependent ER Ca2+ and VGCC-mediated Ca2+ signaling in CA1 pyramidal neurons from 3xTg-AD mice and restored neuronal nitric oxide synthase (nNOS) and hyperphosphorylated tau (p-tau) levels to control levels in the hippocampal subfields and overlying cortex. The LiCl treatment enhanced post-tetanic potentiation (PTP), a form of short-term plasticity in the hippocampus.
Conclusion
The study found that lithium exerts therapeutic effects across several AD-associated early neuronal signaling abnormalities including aberrant Ca2+ signaling, nNOS, and p-tau formation and enhances short-term synaptic plasticity. Lithium could serve as an effective treatment or co-therapeutic for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Neuroscience, The Chicago Medical School, Rosalind Franklin University, North Chicago, IL, USA.
- School of Graduate and Postdoctoral Studies, Rosalind Franklin University, North Chicago, IL, USA.
- Sackler School of Medicine, New York State/American Program of Tel Aviv University, Tel Aviv, Israel.
- Center for Neurodegenerative Disease and Therapeutics, Rosalind Franklin University, North Chicago, IL, USA.
- Discipline of Psychiatry and Behavioral Sciences, The Chicago Medical School, Rosalind Franklin University, North Chicago, IL, USA.
- Captain James A. Lovell Federal Health Care Center, Mental Health, North Chicago, IL, USA.
Zitieren
APA
Wiseman, A. L., Briggs, C. A., Peritt, A., Kapecki, N., Peterson, D. A., Shim, S. S., & Stutzmann, G. E. (2023). Lithium Provides Broad Therapeutic Benefits in an Alzheimer’s Disease Mouse Model. Journal of Alzheimer's Disease, 91(1), 273-290. https://doi.org/10.3233/jad-220758
Vancouver
Wiseman AL, Briggs CA, Peritt A, Kapecki N, Peterson DA, Shim SS, et al. Lithium Provides Broad Therapeutic Benefits in an Alzheimer’s Disease Mouse Model. Journal of Alzheimer's Disease. 2023;91(1):273-290. doi:10.3233/jad-220758
BibTeX
@article{Wiseman2023,
author = {Wiseman, Alyssa L and Briggs, Clark A and Peritt, Ariel and Kapecki, Nicolas and Peterson, Daniel A and Shim, Seong S and Stutzmann, Grace E},
title = {Lithium Provides Broad Therapeutic Benefits in an Alzheimer’s Disease Mouse Model},
journal = {Journal of Alzheimer's Disease},
year = {2023},
volume = {91},
number = {1},
pages = {273--290},
doi = {10.3233/jad-220758}
}
EUVIMED